Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (ATTBF) (CSE:ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse,... more →
Posted in: Press